Chlorhexidine Dihydrochloride
Chlorhexidine (dihydrochloride) |
|||
HY-B1145 | MedChemExpress | 100mg | 142.8 EUR |
Chlorhexidine |
|||
C156-1G | TOKU-E | 1 g | 126 EUR |
Chlorhexidine |
|||
C156-5G | TOKU-E | 5 g | 391.2 EUR |
Chlorhexidine |
|||
HY-B1248 | MedChemExpress | 100mg | 142.8 EUR |
Chlorhexidine |
|||
GP9341-1G | Glentham Life Sciences | 1 g | 112.8 EUR |
Chlorhexidine HCl |
|||
abx187869-1kg | Abbexa | 1 kg | 1045.2 EUR |
Chlorhexidine digluconate |
|||
B3525-50 | ApexBio | 50 mg | 153.6 EUR |
Chlorhexidine HCl |
|||
B1695-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
Description: Chlorhexidine hydrochloride is an antiseptic effective against a wide variety of gram-negative and gram-positive organisms. |
|||
Chlorhexidine HCl |
|||
B1695-50 | ApexBio | 50 mg | 153.6 EUR |
Description: Chlorhexidine hydrochloride is an antiseptic effective against a wide variety of gram-negative and gram-positive organisms. |
|||
Chlorhexidine (digluconate) |
|||
HY-B0608 | MedChemExpress | 5g | 267.6 EUR |
Chlorhexidine digluconate |
|||
TBW00044 | ChemNorm | unit | Ask for price |
Chlorhexidine diacetate salt |
|||
C200-25G | TOKU-E | 25 g | 216 EUR |
Chlorhexidine diacetate salt hydrate |
|||
GA1676-100G | Glentham Life Sciences | 100 g | 370.8 EUR |
Chlorhexidine diacetate salt hydrate |
|||
GA1676-1G | Glentham Life Sciences | 1 g | 55.2 EUR |
Chlorhexidine diacetate salt hydrate |
|||
GA1676-25G | Glentham Life Sciences | 25 g | 132 EUR |
Chlorhexidine diacetate salt hydrate |
|||
GA1676-5G | Glentham Life Sciences | 5 g | 84 EUR |
GGACK Dihydrochloride |
|||
1847-5 | Biovision | 5 mg | 382.8 EUR |
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
|||
GGACK Dihydrochloride |
|||
A2582-5 | ApexBio | 5 mg | 282 EUR |
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
|||
PPACK Dihydrochloride |
|||
A2588-10 | ApexBio | 10 mg | 423.6 EUR |
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
|||
PPACK Dihydrochloride |
|||
A2588-25 | ApexBio | 25 mg | 908.4 EUR |
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
|||
PPACK Dihydrochloride |
|||
A2588-5 | ApexBio | 5 mg | 265.2 EUR |
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
|||
AT7867 dihydrochloride |
|||
A3199-10 | ApexBio | 10 mg | 408 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
A3199-100 | ApexBio | 100 mg | 2210.4 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
A3199-5 | ApexBio | 5 mg | 320.4 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
A3199-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 344.4 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
A3199-50 | ApexBio | 50 mg | 1537.2 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
Canertinib dihydrochloride |
|||
A3276-10 | ApexBio | 10 mg | 129.6 EUR |
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
Canertinib dihydrochloride |
|||
A3276-100 | ApexBio | 100 mg | 226.8 EUR |
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
Canertinib dihydrochloride |
|||
A3276-50 | ApexBio | 50 mg | 177.6 EUR |
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
Inolitazone dihydrochloride |
|||
A3499-5 | ApexBio | 5 mg | 837.6 EUR |
Description: Description:IC50 Value: 0.8 nM [1]Inolitazone(RS5444) is a novel high-affinity PPARgamma agonist, which activates PPARgamma with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARgamma. |
|||
Alexidine dihydrochloride |
|||
A4542-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells. |
|||
Alexidine dihydrochloride |
|||
A4542-50 | ApexBio | 50 mg | 220.8 EUR |
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells. |
|||
Vatalanib Dihydrochloride |
|||
20-abx076544 | Abbexa |
|
|
DMPQ Dihydrochloride |
|||
20-abx076714 | Abbexa |
|
|
H89 Dihydrochloride |
|||
20-abx076747 | Abbexa |
|
|
LDK378 dihydrochloride |
|||
A3544-10 | ApexBio | 10 mg | 186 EUR |
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
LDK378 dihydrochloride |
|||
A3544-100 | ApexBio | 100 mg | 331.2 EUR |
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
LDK378 dihydrochloride |
|||
A3544-5 | ApexBio | 5 mg | 150 EUR |
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
LDK378 dihydrochloride |
|||
A3544-5.1 | ApexBio | 10 mM (in 1mL H2O) | 184.8 EUR |
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
LDK378 dihydrochloride |
|||
A3544-50 | ApexBio | 50 mg | 240 EUR |
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
Mibefradil dihydrochloride |
|||
A3605-10 | ApexBio | 10 mg | 315.6 EUR |
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
|||
Mibefradil dihydrochloride |
|||
A3605-25 | ApexBio | 25 mg | 663.6 EUR |
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
|||
Mibefradil dihydrochloride |
|||
A3605-5 | ApexBio | 5 mg | 201.6 EUR |
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
|||
Mibefradil dihydrochloride |
|||
A3605-50 | ApexBio | 50 mg | 1195.2 EUR |
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
|||
Pramipexole dihydrochloride |
|||
A3733-20 | ApexBio | 20 mg | 129.6 EUR |
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
|||
Pramipexole dihydrochloride |
|||
A3733-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
|||
Pramipexole dihydrochloride |
|||
A3733-50 | ApexBio | 50 mg | 157.2 EUR |
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
|||
Retigabine dihydrochloride |
|||
A3758-10 | ApexBio | 10 mg | 164.4 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
A3758-100 | ApexBio | 100 mg | 522 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
A3758-5 | ApexBio | 5 mg | 126 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
A3758-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 170.4 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
A3758-50 | ApexBio | 50 mg | 325.2 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Veliparib dihydrochloride |
|||
A3958-10 | ApexBio | 10 mg | 177.6 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
A3958-200 | ApexBio | 200 mg | 1002 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
A3958-5 | ApexBio | 5 mg | 150 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
A3958-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 139.2 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
A3958-50 | ApexBio | 50 mg | 421.2 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Piperazine Dihydrochloride |
|||
abx180858-100g | Abbexa | 100 g | 276 EUR |
Pramipexole dihydrochloride |
|||
20-abx180860 | Abbexa |
|
|
IT1t dihydrochloride |
|||
B5650-10 | ApexBio | 10 mg | 385.2 EUR |
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
|||
IT1t dihydrochloride |
|||
B5650-100 | ApexBio | 100 mg | 2100 EUR |
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
|||
IT1t dihydrochloride |
|||
B5650-25 | ApexBio | 25 mg | 710.4 EUR |
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
|||
IT1t dihydrochloride |
|||
B5650-5 | ApexBio | 5 mg | 243.6 EUR |
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
|||
IT1t dihydrochloride |
|||
B5650-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 261.6 EUR |
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
|||
IT1t dihydrochloride |
|||
B5650-50 | ApexBio | 50 mg | 1232.4 EUR |
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
|||
Cystamine dihydrochloride |
|||
B5785-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
Cystamine dihydrochloride |
|||
B5785-50 | ApexBio | 50 mg | 134.4 EUR |
Fluphenazine dihydrochloride |
|||
B6132-100 | ApexBio | 100 mg | 180 EUR |
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons. |
|||
Fluphenazine dihydrochloride |
|||
B6132-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 201.6 EUR |
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons. |
|||
Dilazep dihydrochloride |
|||
B6316-50 | ApexBio | 50 mg | 321.6 EUR |